UK-based protein discovery company Peptone has raised USD 40 million in a Series A funding round co-led by F-Prime Capital and Bessemer Venture Partners, with participation from Walden Catalyst Ventures, Novartis’s venture arm dRX Capital, and others. This round brings the company’s total funds raised to date to USD 42 million.
The proceeds will be injected into the company’s growth efforts including building its laboratory facilities in Switzerland, acquiring advanced imaging machinery and equipment for the facility, expanding its team to 25 people from 14 at present, and identifying drug candidates for five protein targets to advance toward pre-clinical validation in 14 months.
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.